JeromeJeffreyFederspielMDPhD

PubMed

• 89 citations
  Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008.
  Jerome J. Federspiel, Sally C. Stearns, Amanda Peppercorn, Vivian H. Chu, Vance G. Fowler
  Archives of Internal Medicine. 2012-02-27
• 27 citations
  Use of stress testing and diagnostic catheterization after coronary stenting: association of site-level patterns with patient characteristics and outcomes in 247,052 M...
  Bimal R. Shah, Lisa A. McCoy, Jerome J. Federspiel, Daniel W. Mudrick, Patricia A. Cowper
  Journal of the American College of Cardiology. 2013-07-30
• 36 citations
  Clinical Implications of Referral Bias in the Diagnostic Performance of Exercise Testing for Coronary Artery Disease
  Joseph A. Ladapo, Saul Blecker, Michael Elashoff, Jerome J. Federspiel, Dorice Vieira
  Journal of the American Heart Association. 2013-12-19

Journal Articles

• Fibrous solitary tumor of the vulva resulting in spinal metastasis: a case report  
  Pearre DC, Federspiel JJ, Grumbine FC., Gynecol Oncol Rep, 1/1/2017
• Antihypertensive Adherence and Outcomes Among Community‐Dwelling Medicare Beneficiaries: The Atherosclerosis Risk in Communities Study  
  Jerome J Federspiel, Carla A Sueta, Salim S Virani, Patricia P Chang, Journal of Evaluation in Clinical Practice
• Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among inten...  
  Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M., Infect Control Hosp Epidemiol, 1/1/2007

Lectures

• Duration of hospitalization following cesarean section: facility variation and associations with readmission rates. 
  1/1/2018
• Use of intravenous tissue plasminogen activator in patients with a a stroke (stroke mimics): Findings from the Get with the Guidelines Stroke Registry. 
  1/1/2016
• Initial reports on the safety of intravenous tissue plasminogen activator in acute ischemic stroke patients taking novel anticoagulants 
  1/1/2015
• Does receiving long-term care in community versus facility settings affect emergency department use? 
  1/1/2015
• Facility versus community long-term care: impacts on Medicare inpatient expenditures. 
  1/1/2014
• Risk of intracranial hemorrhage among acute ischemic stroke patients receiving prior antiplatelet therapy and treated with intravenous tissue plasminogen activator. 
  1/1/2014
• Health care utilization preceding and following coronary angiography among Medicare beneficiaries. 
  1/1/2014
• STEMI occurring in hospitalized patients is associated with less aggressive care and higher mortality than outpatient STEMI. 
  1/1/2013
• Medicare Part D medication use in a community cohort with hypertension: The Atherosclerosis Risk in Communities (ARIC) Study. 
  1/1/2013
• Predictors of medication adherence: results from the atherosclerosis risk in communities (ARIC) study. 
  1/1/2013
• Referral bias in the diagnostic performance of exercise testing with imaging for coronary artery disease. 
  1/1/2012
• Health outcomes and resource use trajectories when treatments affect survival and costs 
  1/1/2012
• Exercise stress testing modality after percutaneous coronary intervention choice of modality and implications for resource use: retrospective analysis using the NCDR(R) 
  1/1/2012
• Characteristics and trends in admissions for bacterial infective endocarditis in the United States: 1999-2008. 
  1/1/2011
• Effects of stress testing on outcomes for Medicare beneficiaries with acute coronary syndromes. 
  1/1/2011
• Stress testing is associated with increased repeat revascularization rates following multivessel coronary revascularization. 
  1/1/2011
• Drug-eluting stents are associated with decreased mortality among Medicare beneficiaries admitted with acute coronary syndromes 
  1/1/2010
• The changing profile of Medicare beneficiaries receiving drug-eluting stents after myocardial infarction 
  1/1/2010
• Diminishing racial disparities in the utilization of drug-eluting stents among Medicare beneficiaries: 2003-2004. 
  1/1/2010
• Accounting for heterogeneity in treatment selection: the case of revascularization. 
  1/1/2010
• Drug-eluting stents versus bare metal stents for Medicare beneficiaries with acute coronary syndromes: instrumental variables compared to propensity scores 
  1/1/2010
• Cost-effectiveness of genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome. 
  1/1/2010
• Heterogeneous vancomycin-intermediate susceptibility (hVISA) phenotype in bloodstream isolates of methicillin-resistant Staphylococcus aureus (MRSA) from patients with... 
  1/1/2008
• Genotypic characterization of staphylococcus aureus endocarditis isolates from the international collaboration on endocarditis prospective cohort study. 
  1/1/2007
• Genotypic characteristics of staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections (cSSSI). 
  1/1/2007
• Join now to see all

Other

• Dissertation Title: Observational methods in cardiovascular outcomes research 
  
  1/1/2013